ESC Professional Premium Access

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Congress Presentation

About the speakers

Doctor Moritake Iguchi

Kyoto Medical Centre, Kyoto (Japan)
0 follower

Professor Koji Hasegawa

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)
2 presentations
1 follower

6 more presentations in this session

Impact of inflammatory phenotype on prognostic discrimination for the novel biomarker cellular communication network factor 1 (CCN1) in patients with dilated cardiomyopathy

Speaker: Doctor R. Klingenberg (Bad Nauheim, DE)


NT-proBNP is superior to novel plasma biomarkers for predicting adverse outcome in arrhythmogenic right ventricular cardiomyopathy

Speaker: Doctor O. Wozniak (Warsaw, PL)


Aptamer proteomics for biomarker discovery in heart failure with reduced ejection fraction

Speaker: Doctor J. Cunningham (Boston, US)


Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure

Speaker: Doctor R. Pistulli (Munster, DE)


Heart failure is associated with low circulating levels of secreted frizzled receptor protein 5 (Sfrp5).

Speaker: Mr C. Kelly (Newcastle, AU)


Access the full session

Biomarkers for heart failure 1

Speakers: Doctor M. Iguchi, Professor K. Hasegawa, Doctor R. Klingenberg, Doctor O. Wozniak, Doctor J. Cunningham...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb